0001959173-23-002171.txt : 20230703
0001959173-23-002171.hdr.sgml : 20230703
20230703101723
ACCESSION NUMBER: 0001959173-23-002171
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230703
DATE AS OF CHANGE: 20230703
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 231063903
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Watson David O.
CENTRAL INDEX KEY: 0001657719
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
144
1
primary_doc.xml
144
0001657719
XXXXXXXX
LIVE
0001492422
Apellis Pharmaceuticals, Inc.
001-38276
100 FIFTH AVENUE
WALTHAM
MA
02451
617-977-5700
Watson David O.
Officer
Common
Fidelity Brokerage Services LLC
900 Salem Street
Smithfield
RI
02917
8510
765729.80
116457008
07/03/2023
NASDAQ
Common
01/21/2023
Restricted Stock Vesting
Issuer
N
4478
01/21/2023
Compensation
Common
01/28/2023
Restricted Stock Vesting
Issuer
N
1324
01/28/2023
Compensation
Common
02/10/2023
Restricted Stock Vesting
Issuer
N
1062
02/10/2023
Compensation
Common
02/21/2023
Restricted Stock Vesting
Issuer
N
1646
02/21/2023
Compensation
Y
07/03/2023
03/02/2023
/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Watson